Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
506
-
Total shares
-
217M
-
Shares change
-
-730K
-
Total reported value, excl. options
-
$26.6B
-
Value change
-
-$77.8M
-
Put/Call ratio
-
0.98
-
Number of buys
-
245
-
Number of sells
-
-234
-
Price
-
$122.54
Significant Holders of ALEXION PHARMACEUTICALS INC - COM (ALXN) as of Q3 2016
535 filings reported holding ALXN - ALEXION PHARMACEUTICALS INC - COM as of Q3 2016.
ALEXION PHARMACEUTICALS INC - COM (ALXN) has 506 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 217M shares
.
Largest 10 shareholders include FMR LLC (24.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (19.4M shares), Capital Research Global Investors (15.3M shares), VANGUARD GROUP INC (13.7M shares), STATE STREET CORP (10.1M shares), JENNISON ASSOCIATES LLC (7.14M shares), BAKER BROS. ADVISORS LP (6.54M shares), BlackRock Institutional Trust Company, N.A. (5.97M shares), JPMORGAN CHASE & CO (5.64M shares), and SANDS CAPITAL MANAGEMENT, LLC (5.25M shares).
This table shows the top 506 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.